Showing results (341-350 of 407) with videos related to

Sort By:
Pageof 41
Annals of Neurology|October 11, 2022
Trans-Synaptic Degeneration Following Acute Optic Neuritis in Multiple SclerosisOlwen C Murphy, Elias S Sotirchos, Grigorios Kalaitzidis, et al.
Neurology|October 24, 2019
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial dataMyla D Goldman, Nicholas G LaRocca, Richard A Rudick, et al.
Human Brain Mapping|August 18, 2017
Calibrated imaging reveals altered grey matter metabolism related to white matter microstructure and symptom severity in multiple sclerosisNicholas A Hubbard, Monroe P Turner, Minhui Ouyang, et al.
Genes and Immunity|March 20, 2026
Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patientsSara Benavides, Scott Christley, Kiel M Telesford, et al.
Neurology and Therapy|July 16, 2020
State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple SclerosisMaría José Sá, Ricardo Soares Dos Reis, Ayse Altintas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 17, 2020
Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosisAngeliki G Filippatou, Jeffrey Lambe, Elias S Sotirchos, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 19, 2025
Intranasal insulin for improving cognitive function in multiple sclerosisScott D Newsome, Kathryn C Fitzgerald, Abbey Hughes, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 30, 2017
Radiologically isolated syndrome in children: Clinical and radiologic outcomesNaila Makhani, Christine Lebrun, Aksel Siva, et al.
Multiple Sclerosis and Related Disorders|November 24, 2019
Technology-enabled comprehensive characterization of multiple sclerosis in clinical practiceLaura E Baldassari, Kunio Nakamura, Brandon P Moss, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 12, 2019
Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosisElias S Sotirchos, Natalia Gonzalez-Caldito, Blake E Dewey, et al.
Pageof 41